Usefulness of Lipoprotein-Associated Phospholipase A2 Activity and C-Reactive Protein in Identifying High-Risk Smokers for Atherosclerotic Cardiovascular Disease (from the Atherosclerosis Risk in Communities Study).

No abstract is available for this paper.

• Publication year

  2018

• Venue

  American Journal of Cardiology

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjcard.2018.01.020PMID 29525060PMCID PMC5927844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA).

  2017cited by this paper
• The association between cigarette smoking and inflammation: The Genetic Epidemiology Network of Arteriopathy (GENOA) study

  2017cited by this paper
• Smoking intensity (pack/day) is a better measure than pack-years or smoking status for modeling cardiovascular disease outcomes.

  2017cited by this paper
• Association of Long-term, Low-Intensity Smoking With All-Cause and Cause-Specific Mortality in the National Institutes of Health–AARP Diet and Health Study

  2017cited by this paper
• Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk

  2017cited by this paper
• Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study

  2016cited by this paper
• Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

  2016cited by this paper
• Relationship of Cigarette Smoking With Inflammation and Subclinical Vascular Disease: The Multi-Ethnic Study of Atherosclerosis

  2015cited by this paper
• The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General, 2014Us Department of Health and Human Services Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for: Critique

  2015cited by this paper
• High sensitivity C-reactive protein (Hs-CRP) remains highly stable in long-term archived human serum.

  2014cited by this paper
• Darapladib for preventing ischemic events in stable coronary heart disease.

  2014cited by this paper
• Cigarette smoking and variations in systemic immune and inflammation markers.

  2014cited by this paper
• 21st-century hazards of smoking and benefits of cessation in the United States.

  2013cited by this paper
• Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

  2010cited by this paper
• Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions.

  2010cited by this paper
• Absolute and Attributable Risks of Heart Failure Incidence in Relation to Optimal Risk Factors

  2009cited by this paper
• The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort.

  2007cited by this paper
• Mortality in relation to smoking: 50 years' observations on male British doctors

  2004cited by this paper
• A modified poisson regression approach to prospective studies with binary data.

  2004cited by this paper
• Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study

  2004cited by this paper
• Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

  2003cited by this paper
• Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.

  1999cited by this paper
• C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

  1998cited by this paper
• Vitamin C intake and susceptibility to pneumonia.

  1997cited by this paper
• Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience.

  1996cited by this paper
• Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study.

  1993cited by this paper
• The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

  1989cited by this paper
• The National Survey of Stroke. National Institute of Neurological and Communicative Disorders and Stroke.

  1980cited by this paper
• National Institute of Neurological and Communicative Disorders and Stroke. The dementias: hope through research.

  1980cited by this paper

• Biomarkers

  2021cites this paper
• A novel prognosis prediction model, including cytotoxic T lymphocyte‐associated antigen‐4, ischemia‐modified albumin, lipoprotein‐associated phospholipase A2, glial fibrillary acidic protein, and homocysteine, for ischemic stroke in the Chinese hypertensive population

  2021cites this paper
• Increased Pericardial Adipose Tissue in Smokers

  2021cites this paper
• The use of blood biomarkers in precision medicine for the primary prevention of atherosclerotic cardiovascular disease: a review

  2021cites this paper
• Expression of Hypoxia-Inducible Factor-1α (HIF1A) and Lp-PLA2 in Low, Intermediate, and High Cardiovascular Disease Risk Population

  2020cites this paper
• Inflammatory Biomarkers for Cardiovascular Risk Stratification in Familial Hypercholesterolemia.

  2020cites this paper
• Biomarkers for Prediction of Cardiovascular Events in Community-Dwelling Adults Aged 40 or Older.

  2019cites this paper
• No effect of vitamin D administration plus dietary intervention on emerging cardiovascular risk factors in patients with metabolic syndrome

  2019cites this paper
• Atypical Antipsychotic Administration in Schizophrenic Patients Leads to Elevated Lipoprotein‐Associated Phospholipase A2 Levels and Increased Cardiovascular Risk: A Retrospective Cohort Study

  2018cites this paper
• [Metabolic syndrome and concentrations of uric acid and ultrasensitive C-reactive protein].

  2017cites this paper